• Global Collaboration Enables Headway On Rare Neuroendocrine Tumors

    Clinical Research News | Researchers in Madrid recently wrapped up the largest-yet genomic study of rare neuroendocrine tumors, known as pheochromocytomas and paragangliomas, which identified a seemingly perfect panel of metastatic disease markers as well as a group of patients who could potentially benefit from immunotherapy. The objective here is a better means to predict, at the time of diagnosis of the primary tumor, whether patients will be immediately affected by cancer spread.

    Apr 12, 2023
  • Multi-Purpose Cancer Drug Could Extend Life Of Terminally Ill Cancer Patients

    Clinical Research News | A small company based in Norway is taking on the global-sized challenge of cancer treatment, notably including solid tumors and hematological malignancies. The means is a promising, highly specific drug, known as ATX-101, whose molecular target orchestrates many different processes in the cells.

    Apr 11, 2023
  • Liquid Biopsies Could Help Speed Up Lung Cancer Clinical Trials

    Clinical Research News | Circulating tumor DNA (ctDNA) holds potential as a biomarker in lung cancer clinical trials as an added and easier-to-monitor endpoint to survival rates for measuring treatment efficacy. This was one of the key findings of her most recent work, where ctDNA was also shown to outperform clinical responses assessed on CT scans in the prediction of survival.

    Apr 6, 2023
  • Dr. Su Golder on Reporting Adverse Events in Clinical Research

    Clinical Research News | Su Golder, associate professor and senior research fellow in the Department of Health Sciences at the University of York, speaks with the Scope of Things podcast host Deborah Borfitz about adverse event reporting and the challenges that hinder its consistent practice in the health sciences community.

    Apr 4, 2023